Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
University of Michigan · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT06007404
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 14–18 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 175
- US sites recruiting
- 1
- Study start
- September 6, 2023
- Record last updated
- October 15, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents. The hypothesis of this study is that adolescents at risk for metabolic disease have enhanced MiMo related activities leading to insulin resistance.
Conditions: Type 2 Diabetes; Insulin Resistance; Obesity; Metabolic Disease; PreDiabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Between 14 and 18 years of age
- Tanner stage 4 or 5 (mature adult stage of puberty)
- Normal weight (BMI ≥ 5th percentile \& \< 85th percentile), overweight (BMI > 86th percentile) \& \< 94th percentile), obese weight (BMI percentile ≥ 95th percentile), and/or pre-diabetes (HbA1c > 5.7%)
- For Type 2 Diabetes cohort, diagnosis of Type 2 Diabetes
Exclusion Criteria
- Currently pregnant
- Use medications known to affect glucose metabolism (immunosuppressive medications, cancer medications, or high dose steroids), unless prescribed for Type 2 Diabetes management
- Prior diagnosis of autoimmune disease, cancer, or a cognitive or perceptual disability that would inhibit following directions of study staff
- Allergies or intolerance to milk, soy, or palm oil
Recruiting US locations
University of Michigan
Ann Arbor, MI 48109
Study contacts (from the official record)
- The Singer Lab Team · (734) 615-4938 · MiMoStudy@med.umich.edu
Similar studies in Michigan
All weight loss studies in Michigan →- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Troy, MI + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Southfield, MI + 13 other US sites
- Eligibility basics
- Ages 10–18
- RecruitingPhase 2
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Alveus Therapeutics, Inc.
- Location
- Farmington Hills, MI + 19 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Morphic Medical Inc.
- Location
- Ann Arbor, MI + 25 other US sites
- Eligibility basics
- Ages 22–65